Gemcitabine hydrochloride and Eprex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemcitabine hydrochloride (gemcitabine hydrochloride) and Eprex (epoetin alfa). Common drug interactions include anaemia among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Gemcitabine hydrochloride and Eprex. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Gemcitabine hydrochloride?

Gemcitabine hydrochloride has active ingredients of gemcitabine hydrochloride. eHealthMe is studying from 14,775 Gemcitabine hydrochloride users. Check the latest studies of Gemcitabine hydrochloride.

What is Eprex?

Eprex has active ingredients of epoetin alfa. eHealthMe is studying from 5,554 Eprex users. Check the latest studies of Eprex.

On Jul, 19, 2026

11 people who take Gemcitabine hydrochloride and Eprex together, and have interactions are studied.

Gemcitabine hydrochloride and Eprex drug interactions.

What are the common drug interactions of Gemcitabine Hydrochloride and Eprex, by gender? *:

female:

Anaemia (lack of blood)
Empyema (collection of pus in a cavity in the body)
General physical health deterioration (weak health status)
Granulocytopenia (lack of granulocyte)
Hypertension (high blood pressure)
Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Oedema peripheral (superficial swelling)
Pneumonia
Thrombocytopenia (decrease of platelets in blood)

male:

Neutropenia (an abnormally low number of neutrophils)
Thrombocytopenia (decrease of platelets in blood)
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Jaundice cholestatic
Lung adenocarcinoma (a form of non-small cell lung cancer)
Radiation pneumonitis (inflammation of lung due to radiation)
Anaemia (lack of blood)
Granulocytopenia (lack of granulocyte)
Pneumonia
Leukopenia (less number of white blood cells in blood)

What are the common drug interactions of Gemcitabine Hydrochloride and Eprex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Granulocytopenia (lack of granulocyte)
Neutropenia (an abnormally low number of neutrophils)
Pneumonia
Thrombocytopenia (decrease of platelets in blood)
Leukopenia (less number of white blood cells in blood)
Infectious pleural effusion (infectious fluid in the lung)
Empyema (collection of pus in a cavity in the body)
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Jaundice cholestatic

50-59:

n/a

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
General physical health deterioration (weak health status)
Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
Hypertension (high blood pressure)
Lung adenocarcinoma (a form of non-small cell lung cancer)
Metastases to central nervous system (cancer spreads to central nervous system)
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Pulmonary toxicity (side effects on the lungs)
Radiation pneumonitis (inflammation of lung due to radiation)

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 4 people, 36.36%
Weight Decreased: 2 people, 18.18%
Pneumonia: 2 people, 18.18%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 18.18%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 18.18%
Chest Pain: 2 people, 18.18%
Anaemia (lack of blood): 2 people, 18.18%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 18.18%
Pancreatic Neoplasm (pancreatic tumour): 1 person, 9.09%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine hydrochloride and Eprex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously